Apogee Therapeutics (APGE) Prepaid Assets (2022 - 2026)
Apogee Therapeutics (APGE) posted quarterly Prepaid Assets of $3.4 million for Q1 2026, up 474.57% year-over-year from $586000.0 in Q1 2025, and up 456.53% quarter-over-quarter from $605000.0 in Q4 2025.
Apogee Therapeutics (APGE) Prepaid Assets (2022 - 2026) Analysis & Trends
Apogee Therapeutics (APGE) has reported Prepaid Assets for 5 consecutive years, with $3.4 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Prepaid Assets rose 474.57% year-over-year to $3.4 million; the TTM figure through Mar 2026 stood at $3.4 million (up 474.57% YoY), while the FY2025 annual figure was $605000.0, down 93.32% from the prior year.
- Prepaid Assets rose to $3.4 million in Q1 2026 per APGE's latest filing, from $605000.0 in the prior quarter.
- Across five years, Prepaid Assets topped out at $10.7 million in Q2 2025 and bottomed at $165000.0 in Q4 2022.
- Historically, Prepaid Assets has averaged $4.0 million across 5 years, with a median of $3.4 million in 2026.
- On a YoY basis, Prepaid Assets climbed as much as 1771.21% in 2025 and fell as far as 93.32% in 2025.
- Apogee Therapeutics' Prepaid Assets stood at $165000.0 in 2022, then jumped by 1687.88% to $2.9 million in 2023, then surged by 207.12% to $9.1 million in 2024, then sank by 93.32% to $605000.0 in 2025, then surged by 456.53% to $3.4 million in 2026.
- Business Quant data shows APGE's Prepaid Assets at $3.4 million in Q1 2026, $605000.0 in Q4 2025, and $7.4 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | Apogee Therapeutics | 10.14 Bn | 9.16 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 19.81 Mn |
| Mar 31, 2026 | 3.37 Mn |
| Dec 31, 2025 | 605,000.00 |
| Sep 30, 2025 | 7.41 Mn |
| Jun 30, 2025 | 10.70 Mn |
| Mar 31, 2025 | 586,000.00 |
| Dec 31, 2024 | 9.06 Mn |
| Sep 30, 2024 | 396,000.00 |
| Jun 30, 2024 | 5.63 Mn |
| Mar 31, 2024 | 1.69 Mn |
| Dec 31, 2023 | 2.95 Mn |
| Sep 30, 2023 | 3.57 Mn |
| Jun 30, 2023 | 5.60 Mn |
| Dec 31, 2022 | 165,000.00 |